Lista de obras -

'Missed' oesophageal adenocarcinoma and high-grade dysplasia in Barrett's oesophagus patients: A large population-based study.

artículo científico publicado en 2017

Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study

artículo científico publicado en 2019

Blood biomarkers for early diagnosis of oesophageal cancer: a systematic review

artículo científico publicado en 2017

Clinical tumor staging of adenocarcinoma of the esophagus and esophagogastric junction

artículo científico publicado en 2015

Comparison of diagnostic criteria for polycythaemia vera

artículo científico publicado en 2007

Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility.

artículo científico publicado en 2015

Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies?

scientific article published on 20 July 2020

Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinom

scientific article published on 22 November 2019

External validation of a model to determine risk of progression of Barrett's oesophagus to neoplasia

artículo científico publicado en 2019

Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer

scientific article published on 06 February 2014

Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma.

artículo científico publicado en 2018

High PTGS2 expression in post neoadjuvant chemotherapy treated oesophageal adenocarcinoma is associated with improved survival: a population-based cohort study

scientific article published on 25 January 2019

Identification of galanin and its receptor GalR1 as novel determinants of resistance to chemotherapy and potential biomarkers in colorectal cancer

artículo científico publicado en 2012

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma

artículo científico publicado en 2019

Implementing prognostic and predictive biomarkers in CRC clinical trials

artículo científico publicado en 2011

Machine learning to predict early recurrence after oesophageal cancer surgery

scientific article published on 30 January 2020

Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies

artículo científico publicado en 2017

Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes

scholarly article by Andrew McGuigan et al published 21 November 2018 in World Journal of Gastroenterology

Pharmacogenomic profiling and pathway analyses identify MAPK-dependent migration as an acute response to SN38 in p53 null and p53-mutant colorectal cancer cells.

artículo científico publicado en 2012

Re: test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.

artículo científico publicado en 2015

Response to: 'Unified definition of relapse-free survival should be used for evaluating survival benefit in oesophageal adenocarcinoma' by Li

artículo científico publicado en 2020

Sex hormone receptor expression and survival in esophageal adenocarcinoma: a prospective cohort study

scientific article published on 19 October 2018

The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation

artículo científico publicado en 2020

The multiple roles of the IAP super-family in cancer

artículo científico publicado en 2020

Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction

scientific article published on 17 May 2019

Vitamin D receptor as a marker of prognosis in oesophageal adenocarcinoma: a prospective cohort study

scientific article published on 28 September 2018

Lista de obras de

'Missed' oesophageal adenocarcinoma and high-grade dysplasia in Barrett's oesophagus patients: A large population-based study.

Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study

Blood biomarkers for early diagnosis of oesophageal cancer: a systematic review

Clinical tumor staging of adenocarcinoma of the esophagus and esophagogastric junction

Comparison of diagnostic criteria for polycythaemia vera

Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility.

Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies?

Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinom

External validation of a model to determine risk of progression of Barrett's oesophagus to neoplasia

Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer

Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma.

High PTGS2 expression in post neoadjuvant chemotherapy treated oesophageal adenocarcinoma is associated with improved survival: a population-based cohort study

Identification of galanin and its receptor GalR1 as novel determinants of resistance to chemotherapy and potential biomarkers in colorectal cancer

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma

Implementing prognostic and predictive biomarkers in CRC clinical trials

Machine learning to predict early recurrence after oesophageal cancer surgery

Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies

Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes

Pharmacogenomic profiling and pathway analyses identify MAPK-dependent migration as an acute response to SN38 in p53 null and p53-mutant colorectal cancer cells.

Re: test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.

Response to: 'Unified definition of relapse-free survival should be used for evaluating survival benefit in oesophageal adenocarcinoma' by Li

Sex hormone receptor expression and survival in esophageal adenocarcinoma: a prospective cohort study

The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation

The multiple roles of the IAP super-family in cancer

Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction

Vitamin D receptor as a marker of prognosis in oesophageal adenocarcinoma: a prospective cohort study